Marinomed Collaborates With Boehringer Ingelheim For Anti-Viral Nasal Spray
Marinomed said that the nasal spray is based on its anti-viral respiratory technology platform mavirex. ‘mavirex’ is Marinomed’s proprietary anti-viral respiratory technology platform to develop therapies that target
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.